Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Diagnostic Radiopharmaceuticals and Contrast Media market report explains the definition, types, applications, major countries, and major players of the Diagnostic Radiopharmaceuticals and Contrast Media market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Guerbet
Bracco Imaging
Lantheus
Amag Pharmaceuticals
Medtronic
Bayer Healthcare
Mallinckrodt
Daiichi Sankyo
Nordion
GE Healthcare
By Type:
Radiopharmaceuticals
Contrast Media
By End-User:
Diagnostic
Therapeutic
Ionizing Radiation based Radioimaging
Non-Ionizing Radiation based Radioimaging
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Diagnostic Radiopharmaceuticals and Contrast Media Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Diagnostic Radiopharmaceuticals and Contrast Media Outlook to 2028- Original Forecasts
-
2.2 Diagnostic Radiopharmaceuticals and Contrast Media Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Diagnostic Radiopharmaceuticals and Contrast Media Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Diagnostic Radiopharmaceuticals and Contrast Media Market- Recent Developments
-
6.1 Diagnostic Radiopharmaceuticals and Contrast Media Market News and Developments
-
6.2 Diagnostic Radiopharmaceuticals and Contrast Media Market Deals Landscape
7 Diagnostic Radiopharmaceuticals and Contrast Media Raw Materials and Cost Structure Analysis
-
7.1 Diagnostic Radiopharmaceuticals and Contrast Media Key Raw Materials
-
7.2 Diagnostic Radiopharmaceuticals and Contrast Media Price Trend of Key Raw Materials
-
7.3 Diagnostic Radiopharmaceuticals and Contrast Media Key Suppliers of Raw Materials
-
7.4 Diagnostic Radiopharmaceuticals and Contrast Media Market Concentration Rate of Raw Materials
-
7.5 Diagnostic Radiopharmaceuticals and Contrast Media Cost Structure Analysis
-
7.5.1 Diagnostic Radiopharmaceuticals and Contrast Media Raw Materials Analysis
-
7.5.2 Diagnostic Radiopharmaceuticals and Contrast Media Labor Cost Analysis
-
7.5.3 Diagnostic Radiopharmaceuticals and Contrast Media Manufacturing Expenses Analysis
8 Global Diagnostic Radiopharmaceuticals and Contrast Media Import and Export Analysis (Top 10 Countries)
-
8.1 Global Diagnostic Radiopharmaceuticals and Contrast Media Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Diagnostic Radiopharmaceuticals and Contrast Media Export by Region (Top 10 Countries) (2017-2028)
9 Global Diagnostic Radiopharmaceuticals and Contrast Media Market Outlook by Types and Applications to 2022
-
9.1 Global Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Contrast Media Consumption and Growth Rate (2017-2022)
-
9.2 Global Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Diagnostic Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Therapeutic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Ionizing Radiation based Radioimaging Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Non-Ionizing Radiation based Radioimaging Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Diagnostic Radiopharmaceuticals and Contrast Media Market Analysis and Outlook till 2022
-
10.1 Global Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.2.2 Canada Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.2.3 Mexico Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.3.2 UK Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.3.3 Spain Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.3.4 Belgium Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.3.5 France Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.3.6 Italy Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.3.7 Denmark Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.3.8 Finland Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.3.9 Norway Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.3.10 Sweden Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.3.11 Poland Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.3.12 Russia Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.3.13 Turkey Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.4.2 Japan Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.4.3 India Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.4.4 South Korea Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.4.5 Pakistan Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.4.6 Bangladesh Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.4.7 Indonesia Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.4.8 Thailand Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.4.9 Singapore Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.4.10 Malaysia Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.4.11 Philippines Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.4.12 Vietnam Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.5.2 Colombia Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.5.3 Chile Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.5.4 Argentina Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.5.5 Venezuela Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.5.6 Peru Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.5.7 Puerto Rico Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.5.8 Ecuador Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.6.2 Kuwait Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.6.3 Oman Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.6.4 Qatar Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.6.5 Saudi Arabia Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.6.6 United Arab Emirates Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.7.2 South Africa Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.7.3 Egypt Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.7.4 Algeria Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
-
10.8.2 New Zealand Diagnostic Radiopharmaceuticals and Contrast Media Consumption (2017-2022)
11 Global Diagnostic Radiopharmaceuticals and Contrast Media Competitive Analysis
-
11.1 Guerbet
-
11.1.1 Guerbet Company Details
-
11.1.2 Guerbet Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Guerbet Diagnostic Radiopharmaceuticals and Contrast Media Main Business and Markets Served
-
11.1.4 Guerbet Diagnostic Radiopharmaceuticals and Contrast Media Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Bracco Imaging
-
11.2.1 Bracco Imaging Company Details
-
11.2.2 Bracco Imaging Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Bracco Imaging Diagnostic Radiopharmaceuticals and Contrast Media Main Business and Markets Served
-
11.2.4 Bracco Imaging Diagnostic Radiopharmaceuticals and Contrast Media Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Lantheus
-
11.3.1 Lantheus Company Details
-
11.3.2 Lantheus Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Lantheus Diagnostic Radiopharmaceuticals and Contrast Media Main Business and Markets Served
-
11.3.4 Lantheus Diagnostic Radiopharmaceuticals and Contrast Media Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Amag Pharmaceuticals
-
11.4.1 Amag Pharmaceuticals Company Details
-
11.4.2 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals and Contrast Media Main Business and Markets Served
-
11.4.4 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals and Contrast Media Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Medtronic
-
11.5.1 Medtronic Company Details
-
11.5.2 Medtronic Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Medtronic Diagnostic Radiopharmaceuticals and Contrast Media Main Business and Markets Served
-
11.5.4 Medtronic Diagnostic Radiopharmaceuticals and Contrast Media Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Bayer Healthcare
-
11.6.1 Bayer Healthcare Company Details
-
11.6.2 Bayer Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Bayer Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Main Business and Markets Served
-
11.6.4 Bayer Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Mallinckrodt
-
11.7.1 Mallinckrodt Company Details
-
11.7.2 Mallinckrodt Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Mallinckrodt Diagnostic Radiopharmaceuticals and Contrast Media Main Business and Markets Served
-
11.7.4 Mallinckrodt Diagnostic Radiopharmaceuticals and Contrast Media Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Daiichi Sankyo
-
11.8.1 Daiichi Sankyo Company Details
-
11.8.2 Daiichi Sankyo Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Daiichi Sankyo Diagnostic Radiopharmaceuticals and Contrast Media Main Business and Markets Served
-
11.8.4 Daiichi Sankyo Diagnostic Radiopharmaceuticals and Contrast Media Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Nordion
-
11.9.1 Nordion Company Details
-
11.9.2 Nordion Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Nordion Diagnostic Radiopharmaceuticals and Contrast Media Main Business and Markets Served
-
11.9.4 Nordion Diagnostic Radiopharmaceuticals and Contrast Media Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 GE Healthcare
-
11.10.1 GE Healthcare Company Details
-
11.10.2 GE Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 GE Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Main Business and Markets Served
-
11.10.4 GE Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Product Portfolio
-
11.10.5 Recent Research and Development Strategies
12 Global Diagnostic Radiopharmaceuticals and Contrast Media Market Outlook by Types and Applications to 2028
-
12.1 Global Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Diagnostic Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Ionizing Radiation based Radioimaging Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Non-Ionizing Radiation based Radioimaging Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Diagnostic Radiopharmaceuticals and Contrast Media Market Analysis and Outlook to 2028
-
13.1 Global Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.2.2 Canada Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.2.3 Mexico Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.3.2 UK Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.3.3 Spain Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.3.4 Belgium Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.3.5 France Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.3.6 Italy Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.3.7 Denmark Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.3.8 Finland Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.3.9 Norway Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.3.10 Sweden Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.3.11 Poland Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.3.12 Russia Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.3.13 Turkey Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.4.2 Japan Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.4.3 India Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.4.4 South Korea Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.4.8 Thailand Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.4.9 Singapore Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.4.11 Philippines Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.5.2 Colombia Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.5.3 Chile Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.5.4 Argentina Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.5.6 Peru Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.6.3 Oman Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.6.4 Qatar Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.7.2 South Africa Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.7.3 Egypt Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.7.4 Algeria Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Diagnostic Radiopharmaceuticals and Contrast Media
-
Figure of Diagnostic Radiopharmaceuticals and Contrast Media Picture
-
Table Global Diagnostic Radiopharmaceuticals and Contrast Media Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Diagnostic Radiopharmaceuticals and Contrast Media Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Radiopharmaceuticals Consumption and Growth Rate (2017-2022)
-
Figure Global Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Global Diagnostic Consumption and Growth Rate (2017-2022)
-
Figure Global Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure Global Ionizing Radiation based Radioimaging Consumption and Growth Rate (2017-2022)
-
Figure Global Non-Ionizing Radiation based Radioimaging Consumption and Growth Rate (2017-2022)
-
Figure Global Diagnostic Radiopharmaceuticals and Contrast Media Consumption by Country (2017-2022)
-
Table North America Diagnostic Radiopharmaceuticals and Contrast Media Consumption by Country (2017-2022)
-
Figure United States Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Canada Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Mexico Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Table Europe Diagnostic Radiopharmaceuticals and Contrast Media Consumption by Country (2017-2022)
-
Figure Germany Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure UK Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Spain Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Belgium Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure France Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Italy Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Denmark Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Finland Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Norway Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Sweden Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Poland Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Russia Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Turkey Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Table APAC Diagnostic Radiopharmaceuticals and Contrast Media Consumption by Country (2017-2022)
-
Figure China Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Japan Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure India Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure South Korea Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Thailand Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Singapore Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Philippines Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Table South America Diagnostic Radiopharmaceuticals and Contrast Media Consumption by Country (2017-2022)
-
Figure Brazil Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Colombia Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Chile Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Argentina Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Peru Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Table GCC Diagnostic Radiopharmaceuticals and Contrast Media Consumption by Country (2017-2022)
-
Figure Bahrain Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Oman Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Qatar Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Table Africa Diagnostic Radiopharmaceuticals and Contrast Media Consumption by Country (2017-2022)
-
Figure Nigeria Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure South Africa Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Egypt Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Algeria Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Table Oceania Diagnostic Radiopharmaceuticals and Contrast Media Consumption by Country (2017-2022)
-
Figure Australia Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Diagnostic Radiopharmaceuticals and Contrast Media Consumption and Growth Rate (2017-2022)
-
Table Guerbet Company Details
-
Table Guerbet Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
Table Guerbet Diagnostic Radiopharmaceuticals and Contrast Media Main Business and Markets Served
-
Table Guerbet Diagnostic Radiopharmaceuticals and Contrast Media Product Portfolio
-
Table Bracco Imaging Company Details
-
Table Bracco Imaging Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bracco Imaging Diagnostic Radiopharmaceuticals and Contrast Media Main Business and Markets Served
-
Table Bracco Imaging Diagnostic Radiopharmaceuticals and Contrast Media Product Portfolio
-
Table Lantheus Company Details
-
Table Lantheus Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lantheus Diagnostic Radiopharmaceuticals and Contrast Media Main Business and Markets Served
-
Table Lantheus Diagnostic Radiopharmaceuticals and Contrast Media Product Portfolio
-
Table Amag Pharmaceuticals Company Details
-
Table Amag Pharmaceuticals Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amag Pharmaceuticals Diagnostic Radiopharmaceuticals and Contrast Media Main Business and Markets Served
-
Table Amag Pharmaceuticals Diagnostic Radiopharmaceuticals and Contrast Media Product Portfolio
-
Table Medtronic Company Details
-
Table Medtronic Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
Table Medtronic Diagnostic Radiopharmaceuticals and Contrast Media Main Business and Markets Served
-
Table Medtronic Diagnostic Radiopharmaceuticals and Contrast Media Product Portfolio
-
Table Bayer Healthcare Company Details
-
Table Bayer Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Main Business and Markets Served
-
Table Bayer Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Product Portfolio
-
Table Mallinckrodt Company Details
-
Table Mallinckrodt Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mallinckrodt Diagnostic Radiopharmaceuticals and Contrast Media Main Business and Markets Served
-
Table Mallinckrodt Diagnostic Radiopharmaceuticals and Contrast Media Product Portfolio
-
Table Daiichi Sankyo Company Details
-
Table Daiichi Sankyo Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo Diagnostic Radiopharmaceuticals and Contrast Media Main Business and Markets Served
-
Table Daiichi Sankyo Diagnostic Radiopharmaceuticals and Contrast Media Product Portfolio
-
Table Nordion Company Details
-
Table Nordion Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nordion Diagnostic Radiopharmaceuticals and Contrast Media Main Business and Markets Served
-
Table Nordion Diagnostic Radiopharmaceuticals and Contrast Media Product Portfolio
-
Table GE Healthcare Company Details
-
Table GE Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Sales, Price, Value and Gross Profit (2017-2022)
-
Table GE Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Main Business and Markets Served
-
Table GE Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Product Portfolio
-
Figure Global Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diagnostic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ionizing Radiation based Radioimaging Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non-Ionizing Radiation based Radioimaging Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast by Country (2022-2028)
-
Table North America Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast by Country (2022-2028)
-
Figure United States Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast by Country (2022-2028)
-
Figure Germany Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast by Country (2022-2028)
-
Figure China Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast by Country (2022-2028)
-
Figure Brazil Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast by Country (2022-2028)
-
Figure Australia Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
